Your shopping cart is currently empty

Calcifediol-d9 (25-hydroxy Vitamin D3-d9) is a deuterated form of Calcifediol. Calcifediol (25-hydroxy Vitamin D3) serves as an effective ligand for the vitamin D receptor (VDR) and is a vitamin D supplement. It is a prohormone in the vitamin D endocrine system (VDES) that, upon hepatic hydroxylation, is converted to its active form, Calcitriol. Calcifediol can rapidly increase serum vitamin D levels.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Calcifediol-d9 (25-hydroxy Vitamin D3-d9) is a deuterated form of Calcifediol. Calcifediol (25-hydroxy Vitamin D3) serves as an effective ligand for the vitamin D receptor (VDR) and is a vitamin D supplement. It is a prohormone in the vitamin D endocrine system (VDES) that, upon hepatic hydroxylation, is converted to its active form, Calcitriol. Calcifediol can rapidly increase serum vitamin D levels. |
| Molecular Weight | 409.7 |
| Formula | C27H44O2 |
| Cas No. | 1539301-45-5 |
| Smiles | C([C@@]12[C@](\C(=C\C=C\3/C(=C)CC[C@H](O)C3)\CCC1)(CC[C@@]2([C@@H](CCCC(C([2H])([2H])[2H])(C([2H])([2H])[2H])O)C)[H])[H])([2H])([2H])[2H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.